AI in Medicine News ・ 🇯🇵 Medicine and AI in Japan

OpenAI Acquires AI Drug Discovery Startup, Intensifying Competition With Anthropic and Google

Japanese media · 10/21 10:37 UTC

On October 20, 2026, OpenAI announced it had acquired Orchestra Bio, a US startup developing AI agents that support drug development project management for biopharmaceutical companies. Orchestra Bio's technology and team will be integrated into Rosalind, OpenAI's AI platform for life sciences. The terms of the deal, including the price, have not been disclosed.

Read the original (Japanese media)

See it in the digest → ・ See this issue →